Insidermedicine Daily News (Video)
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured ...
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured by Google News and The News Room. April 25, 2007 Patients with HIV who are treated with protease inhibitors have an increased risk of heart attack, according to a study published in the New England Journal of Medicine. Combination antiretroviral therapy has had a dramatic effect in reducing illness and death associated with the HIV virus, however an earlier study showed that the risk of heart attacks increased by 17% with every year a patient spent on antiretroviral. It isn’t known, though, whether all antiretroviral drugs carry this risk. The assessment of the role of any specific drug is difficult because patients with HIV usually receive a combination of drugs, and often switch regimens because of the availability of newer substances, adverse events, or drug regimen failure. Previous studies have shown a relationship between the use of protease inhibitors, a class of antiretroviral drug, and cardiovascular disease, but there is little information on the risks associated with another class of antiretroviral therapy called nonnucleoside reverse-transcriptase inhibitors. In this study, more than 23,000 patients infected with the HIV virus were assessed to determine the incidence of heart attack and the association between heart attack and exposure to protease inhibitors or nonnucleoside reverse-transcriptase inhibitors. Confirming the earlier results, the researchers found the risk of having a heart attack increased by 16% per year of exposure to protease inhibitors alone, which is equal to twice the risk over five years. Not such effect was observed with nonnucleoside reverse-transcriptase inhibitors. It is thought that protease inhibitors raise the level of blood lipid, thereby increasing the risk of cardiovascular disease and heart attack. Patients treated with protease inhibitors should have their cholesterol and blood pressure levels monitored, and take steps to reduce their lifestyle-related risk factors. This includes maintaining a healthy weight, eating a low-fat diet rich in fruits in vegetables, and getting regular exercise. Reporting for Insidermedicine, I'm Dr. Susan Sharma.
Show all Visit Show Website http://www.insidermedicine.caRecently Aired
-
HD
1 in 7 Hispanic adults suffers from hearing loss
(June 3, 2015 - Insidermedicine) From Maryland - A new ...
(June 3, 2015 - Insidermedicine) From Maryland - A new report published in JAMA Otolaryngology--Head and Neck Surgery finds that nearly 1 in 7 Hispanic/Latina adults in the US suffers from some hearing loss. Researchers studied over 16,000 Hispanic/Latino adults, representative of wide range of backgrounds and taken from all over the country. Participants were between 18 and 74 years old. Results showed that, of this group, 15.1% had hearing loss in one ear.
-
HD
Diabetes may have protective effect against amyotrophic lateral sclerosis
(June 1, 2015 - Insidermedicine) From Boston - Diabetes may ...
(June 1, 2015 - Insidermedicine) From Boston - Diabetes may have a protective effect against amyotrophic lateral sclerosis, according to research published in JAMA Neurology. Researchers compared over 3,600 ALS patients to over 365, 000 controls. Participants had an average age of 65.4 years. Nearly 10,000 patients had diabetes. Results showed that diabetes, but not obesity, was linked to a lower risk of ALS.
-
HD
Breastfeeding may lower risk of childhood leukemia
(June 1, 2015 - Insidermedicine) From Israel - According to ...
(June 1, 2015 - Insidermedicine) From Israel - According to a report published in JAMA Paediatrics, breastfeeding may reduce risk of childhood leukaemia. Researchers conducted a meta-analysis comprised of 18 studies. They found that breastfeeding for six months or longer was associated with a 19% reduced risk of childhood leukaemia, when compared to women who didn’t breastfeed at all or who had breastfed for a shorter period of time. There was an 11% reduced risk among those who breastfed, regardless of duration, when compared to those who never breastfed.
-
HD
Metformin may lower risk of glaucoma
(May 29, 2015 - Insidermedicine) From Michigan - The diabetes ...
(May 29, 2015 - Insidermedicine) From Michigan - The diabetes drug metformin may lower risk of developing glaucoma, according to a report published in JAMA Ophthalmology. Researchers studied data on over 150,000 diabetes patients taken from a large managed care network from 2001-2010. Of these, nearly 6,000 developed open-angle glaucoma. Results showed that those who were prescribed the highest amount of metformin over the study period were 25% less likely to develop open-angle glaucoma when compared to those who didn’t take the drug at all.
-
HD
Soy supplements do not appear to improve asthma
(May 29, 2015 - Insidermedicine) From Chicago - Taking soy ...
(May 29, 2015 - Insidermedicine) From Chicago - Taking soy supplements does not improve asthma, according to research published in JAMA. Researchers studied nearly 400 adults and children aged 12 years and older. Participants had poorly controlled asthma and were taking either corticosteroids or leukotrine modifiers, but none were consuming soy. They were then randomized to take either a soy isoflavone supplement 2x a day for six months, or placebo. Results showed that, in contrast to previous research, the soy supplements did not improve lung function or symptoms of asthma
-
HD
More fibre in the diet may lower diabetes risk
(May 28, 2015 - Insidermedicine) From Norway - According to ...
(May 28, 2015 - Insidermedicine) From Norway - According to research published in Diabetologia, adding fibre to the diet may lower risk of developing diabetes. Researchers studied over 12,000 type 2 diabetes patients and over 16,000 controls. Participants were divided into four groups depending on their fibre intake and were followed for an average of 11 years. Results showed that those with the highest fibre intake (over 26 g/day) were are 18% reduced risk of developing diabetes compared to those consuming less than 19g a day
-
HD
Newer contraceptive pills may raise risk of blood clot
(May 28, 2015 - Insidermedicine) From the UK - A ...
(May 28, 2015 - Insidermedicine) From the UK - A new report published in the BMJ finds that some newer contraceptive pills may be linked to risk of blood clot. Researchers studied prescription data from two large databases to examined the link between combined oral contraceptives and VTE. Results showed that users of combined oral contraceptives were at raised risk of VTE compared to non-users. As well, women using newer pills, containing newer types of progesterone hormone, were at around 1.5-1.8x increased risk of VTE than women using older pills.
-
HD
Novel method to prevent diabetes-associated blindness
(May 26, 2015 - Insidermedicine) From Baltimore - A new ...
(May 26, 2015 - Insidermedicine) From Baltimore - A new report published in Proceedings of the National Academy of Sciences examines a novel method to preventing diabetes-related blindness. Researchers studied samples of fluid taken from the eyes of healthy people, those with diabetes but no diabetic retinopathy, and finally, those with diabetic retinopathy. As expected, they found that VEGF plays an important role in blood vessel growth seen in diabetic retinopathy. However, in further experiments with lab-grown human cells and mice, researchers found a protein called angiopoieten-like 4 that played a secondary role. When blocking the action of both VEGF and this secondary protein, researchers were able to significantly reduce blood vessel growth in the lab-grown cells of diabetic retinopathy.
-
HD
Depression raises risk of death in heart failure patients
(May 26, 2015 - Insidermedicine) From London - Depression greatly ...
(May 26, 2015 - Insidermedicine) From London - Depression greatly raises death risk in heart failure patients, according to a report presented at the Heart Failure Association of European Society of Cardiology. Researchers studied over 100 heart failure patients enrolled in an ongoing observational study. Participants were followed for a mean of 302 days. Results showed that those with moderate or severe depression were at 5x increased risk of death compared to those with no or mild depression.
-
HD
Inhaled corticosteroids for COPD may reduce death risk of pneumonia
(May 25, 2015 - Insidermedicine) From Florida - Inhaled corticosteroids ...
(May 25, 2015 - Insidermedicine) From Florida - Inhaled corticosteroids for COPD may reduce death risk of pneumonia, according to research presented at the American Thoracic Society International Conference. Researchers conducted a meta-analysis comprised of 29 randomized trials and six observational studies. Results showed that inhaled corticosteroids actually increased risk of pneumonia in COPD patients, but also reduced the risk of both pneumonia-associated and overall mortality.
